Back

Select your region

Schedule a cord blood consultation

Make an appointment

Stem Cells
Therapies

Stem Cells Therapies

The purpose of banking stem cells is to apply them in the therapy. For the first time cord blood was used in 1988 and since then according to publicly available statistics it has been used over 85 000 times worldwide (including statistics of China).

FamiCord Group stores over 1,000,000 samples of cells of different types and has supplied stem cells for application in clinic for more than 7000 patients. We supply stem cells for standard transplantations (cord blood , bone marrow and mobilized peripheral blood) and cellular therapies. On top of that we provide cell based products in GMP standard for clinical trials.

Stem cells manufactured in our premises helped patients with various diseases and therapeutic areas, including haematological, neurological, ophthalmological, orthopaedical, dermatological disorders.

Check the full list of patients who received stem cell therapy derived from FamiCord labs.

List last update: 06.2026

List of patients who received stem cells from FamiCord Group laboratories

List of patients who received stem cells from FamiCord Group laboratories
Lp. Source Source type Diagnosis Medical field Year of application Therapy Country Age of recipient
1401 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 21
1402 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Denmark 65
1403 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Romania 25
1404 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 27
1405 Apheresis Allogeneic Polycythaemia Vera Hematology 2025 Standard Therapy Germany 61
1406 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 25
1407 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 51
1408 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 70
1409 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 53
1410 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Lithuania 61
1411 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Russian Federation 49
1412 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 36
1413 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 62
1414 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 54
1415 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 74
1416 Apheresis Allogeneic NHL Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy Poland 49
1417 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 62
1418 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2025 Standard Therapy USA 74
1419 Apheresis Allogeneic NHL Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy Argentine 57
1420 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 56
1421 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Belgium 71
1422 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Spain 59
1423 Apheresis Allogeneic Other Myelofibrosis/Myelosclerosis Hematology 2025 Standard Therapy USA 65
1424 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 14
1425 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Denmark 57
1426 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 68
1427 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 51
1428 Apheresis Allogeneic Richter Transformation CDLBCC Hematology 2025 Standard Therapy Germany 68
1429 Apheresis Allogeneic Acute Myelogenous Leukemia-MR Hematology 2025 Standard Therapy Russian Federation 16
1430 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 63
1431 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 66
1432 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 50
1433 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 38
1434 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 43
1435 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 74
1436 Apheresis Allogeneic T-cell Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 51
1437 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 59
1438 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 66
1439 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 68
1440 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 33
1441 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 48
1442 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Netherlands 66
1443 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 57
1444 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2025 Standard Therapy Belgium 56
1445 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 55
1446 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 24
1447 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 61
1448 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 71
1449 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Canada 53
1450 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 62
1451 Apheresis Autologous Mantle Cell Lymphoma Hematology 2025 Standard Therapy Germany 45
1452 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 61
1453 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 32
1454 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2025 Standard Therapy Germany 62
1455 Apheresis Autologous Central Nervous System Lymphoma Hematology 2025 Standard Therapy Germany 75
1456 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 70
1457 Cord Tissue Autologous Autism Neurology 2024 Experimental Therapy Romania 6
1458 Cord Tissue Allogeneic – Related Autism Neurology 2024 Experimental Therapy Romania 6
1459 Cord Tissue Autologous Autism Neurology 2024 Experimental Therapy Romania 4
1460 Cord Tissue Allogeneic – Related Autism Neurology 2024 Experimental Therapy Romania 6
1461 Cord Tissue Allogeneic – Unrelated Degenerative and Traumatic Cartilage Orthopedics 2024 Experimental Therapy Poland 50
1462 Cord Tissue Allogeneic – Unrelated Degenerative and Traumatic Cartilage Orthopedics 2024 Experimental Therapy Poland 49
1463 Cord Tissue Allogeneic – Unrelated Degenerative and Traumatic Cartilage Orthopedics 2024 Experimental Therapy Poland 58
1464 Cord Tissue Allogeneic – Unrelated Graft Versus Host Disease Hematology 2024 Experimental Therapy Poland 7
1465 Cord Tissue Allogeneic – Unrelated Graft Versus Host Disease Hematology 2024 Experimental Therapy Poland 15
1466 Cord Tissue Allogeneic – Unrelated Ovarian Dysfunction Gynecology 2024 Experimental Therapy Poland 48
1467 Cord Tissue Allogeneic – Related Severe Pulmonary Hypertension +Mitral Regurgitation Cardiovascular/Pulmonary 2024 Experimental Therapy Romania 2
1468 Cord Tissue Allogeneic – Unrelated Amyotrophic lateral sclerosis Neurology 2024 Experimental Therapy Poland 57
1469 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2024 Experimental Therapy Poland 68
1470 Cord Tissue Allogeneic – Related Autism Neurology 2024 Experimental Therapy Romania 17
1471 Cord Tissue Autologous Autism Neurology 2024 Experimental Therapy Romania 7
1472 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2024 Experimental Therapy Poland 61
1473 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2024 Experimental Therapy Poland 45
1474 Cord Tissue Allogeneic – Unrelated Amyotrophic lateral sclerosis Neurology 2024 Experimental Therapy Poland 56
1475 Cord Tissue Allogeneic – Unrelated Graft-versus-host disease Hematology 2024 Experimental Therapy Poland 0
1476 Cord Tissue Allogeneic – Unrelated Amyotrophic lateral sclerosis Neurology 2024 Experimental Therapy Poland 39
1477 Cord Tissue Allogeneic – Unrelated GvHD Neurology 2024 Experimental Therapy Poland 9
1478 Cord Tissue Allogeneic – Unrelated Cerebral palsy Neurology 2024 Experimental Therapy Poland 5
1479 Cord Tissue Allogeneic – Unrelated Cerebral palsy Neurology 2024 Experimental Therapy Poland 13
1480 Cord Tissue Allogeneic – Unrelated Leukodystrophy Neurology 2024 Experimental Therapy Poland 1
1481 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2024 Experimental Therapy Poland 7
1482 Cord Tissue Allogeneic – Unrelated Leukodystrophy Neurology 2024 Experimental Therapy Poland 1
1483 Cord Tissue Allogeneic – Unrelated Cerebellar-spinal ataxia Neurology 2024 Experimental Therapy Poland 35
1484 Cord Tissue Allogeneic – Unrelated Leukodystrophy Neurology 2024 Experimental Therapy Poland 1
1485 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2024 Experimental Therapy Poland 4
1486 Cord Blood Autologous Autism Neurology 2024 Experimental Therapy Romania 11
1487 Cord Blood Autologous Autism Neurology 2024 Experimental Therapy Romania 10
1488 Cord Blood Autologous Autism Neurology 2024 Experimental Therapy Romania 6
1489 Cord Blood Autologous Autism Neurology 2024 Experimental Therapy Romania 4
1490 Cord Blood Autologous Autism Neurology 2024 Experimental Therapy Romania 5
1491 Cord Blood Allogeneic Cerebral Palsy Neurology 2024 Experimental Therapy Poland 3
1492 Cord Blood Allogeneic Cerebral Palsy Neurology 2024 Experimental Therapy Poland 7
1493 Cord Blood Autologous CP Neurology 2024 Experimental Therapy Hungary 4
1494 Cord Blood Autologous Pervasive Developmental Disorder Neurology 2024 Experimental Therapy Poland 3
1495 Cord Blood Autologous Pervasive Developmental Disorder Neurology 2024 Experimental Therapy Poland 5
1496 Cord Blood Autologous Pervasive developmental disorder Neurology 2024 Experimental Therapy Poland 4
1497 Cord Blood Allogeneic – Related fanconi aplastic anemia Hematology 2024 Standard Therapy Turkey 12
1498 Cord Blood Autologous Neuroblastoma Neurology 2024 Standard Therapy Poland 4
1499 Cord Blood Autologous Pervasive developmental disorder Neurology 2024 Experimental Therapy Poland 9
1500 Cord Blood Autologous Autism Neurology 2024 Experimental Therapy Slovakia 4